Aphea.Bio

Applied Nature for a Better Agriculture

 
 
 

Aphea.Bio is a leading player in the development of the next generation biological products based on naturally occurring microorganisms. Launched in 2017, Aphea.Bio focuses on products that help reducing fertilizer application and controlling fungal diseases for maize and wheat in a sustainable way.

Aphea.Bio is in a unique position to deliver new and powerful solutions to the market because of its unique innovative research platform and its expertise to discover, isolate, culture and exploit the so far untapped microbial space. Selected beneficial microorganisms, applied via seed treatments or sprayable can result in higher yields under reduced fertilizer regimes or protect crops against the economically most important fungal diseases offering a sustainable alternative to chemical fertilizers and pesticides.

As stated in its mission 'Applied Nature for a Better Agriculture', the company is fully committed to contribute to meeting the ambitions of using at least 20% less fertilizers and halving the use of chemical pesticides by 2030, as outlined in the Farm-to-Fork strategy, a cornerstone of the European Green Deal.

 

“We are delighted to have ECBF on board. Their investment underpins that Aphea.Bio is adding significant value to
tomorrow´s agriculture.”

- Isabel Vercauteren, CEO Aphea.Bio -

Aphea.Bio
Technologiepark 21
B-9052 Gent
Belgium
isabel.vercauteren@aphea.bio
www.aphea.bio
LinkedIn

Get in touch

webres (25).jpg

ECBF Deal Team